baber/WOPTO huggingface dataset:
Patent AU-2017220486-A1 (AU)
Title: Method and apparatus for improved detective quantum efficiency in an X-ray detector
Inventor: KARIM KARIM S
IPC: G01T1/29
Filed: 2017-02-16
Abstract: The disclosure is directed at a method and apparatus for improving method and apparatus for improved modulation transfer function and detective quantum efficiency of X-ray detectors. The method and apparatus include digitizing microelement outputs obtained by micro sensor elements and the generating pixel outputs from these digitized microelement outputs. Each pixel output is the sum of a plurality of weighting factored microelement outputs.
Patent AU-2017228716-A1 (AU)
Title: Vehicle for deposition of explosives in blast holes and method of use
Inventor: DE ANDRADE SANTOS REGINALDO
IPC: F42D1/10
Filed: 2017-09-15
Abstract: VEHICLE FOR DEPOSITION OF EXPLOSIVES IN BLAST HOLES AND METHOD OF USE It describes a vehicle (1) configured for the deposition of explosives in holes (10) of open-pit exploration mines, being this vehicle (1) able to perform all seven steps carried out in the manual explosive deposition process, automatically, completely free of human intervention. It also describes a method of use of the aforementioned vehicle (1). Ils Figure 1 37 = 15 - 12 38-3 37 30 Figure 2
Patent AU-2017232902-A1 (AU)
Title: Composite medical grafts and methods of use and manufacture
Inventor: STEVENS PETER J
IPC: A61L27/20
Filed: 2017-03-16
Abstract: Provided in this disclosure are various composite grafts having a trabecular synthetic scaffold with voids defined in at least a portion of the scaffold and a biological component positioned in at least some of the voids of the scaffold. The grafts may be osteogenic, chondrogenic, osteochondrogenic, or vulnerary in nature. Also provided are methods of using the composite grafts to treat a tissue defect in a subject. Methods of manufacturing are also provided. Grafts are manufactured by additive manufacturing. Agitation may be used to combine composite grafts with additional biological component.
Patent AU-2017240609-A1 (AU)
Title: Isoquinolinyl triazolone complexes
Inventor: CHEN RONGLIANG
IPC: A61P29/00
Filed: 2017-03-30
Abstract: Disclosed is a complex of a compound of Formula 1, a stereoisomer thereof, or a tautomer of the compound of Formula 1 or stereoisomer thereof, and a cyclodextrin, in which the complex is an amorphous solid. This disclosure also relates to materials and methods for preparing the complex, to pharmaceutical compositions which contain the complex, and to the use of the complex to treat Type I hypersensitivity reactions, autoimmune diseases, inflammatory disorders, cancer, non-malignant proliferative disorders, and other conditions associated with BTK.
Patent AU-2017243882-A1 (AU)
Title: A flow modification device having helical strakes and a system and method for modifying flow
Inventor: POTTS ANDREW ELMHIRST
IPC: F15D1/14
Filed: 2017-03-31
Abstract: A flow modification device connectable to a generally cylindrical element adapted for immersion in a fluid medium is provided. The device comprises an elongate body having a length and a generally circular cross-section; a plurality of raised body portions disposed about and extending along the length of the elongate body, the raised body portions having a height between 2% and 10% of a diameter of the body; and an aperture extending through the length of the elongate body, the aperture being adapted to receive the generally cylindrical element such that the flow modification device is arranged about the cylindrical element. The plurality of raised body portions are helically arranged or twisted about a longitudinal axis of the elongate body and are adapted to reduce vortex-induced vibration and/or drag on the cylindrical element when the device is connected to the cylindrical element and the connected device and cylindrical element are immersed in the fluid medium and there is relative movement between the connected device and cylindrical element and the fluid medium.
Patent AU-2017265839-A1 (AU)
Title: Use of carbamate compound for preventing or treating fibromyalgia or functional syndrome associated with fibromyalgia
Inventor: JO MIN JAE
IPC: A61K31/16
Filed: 2017-05-18
Abstract: The present invention relates to a pharmaceutical composition for preventing or treating fibromyalgia or a functional syndrome associated with fibromyalgia, the pharmaceutical composition comprising: a carbamate compound of chemical formula 1 or a pharmaceutically acceptable salt thereof, a solvate or a hydrate; and a pharmaceutically acceptable carrier. The pharmaceutical composition, according to the present invention, may enable the efficient treatment of fibromyalgia or a functional syndrome associated with fibromyalgia.
Patent AU-2017280351-A1 (AU)
Title: Drug coated balloons and techniques for increasing vascular permeability
Inventor: ALSTON STEVEN M
IPC: A61L29/08
Filed: 2017-06-23
Abstract: The present disclosure is directed toward drug coated balloons, and in particular to drug coated balloons having a microcrystalline structure and techniques for increasing vascular permeability for drug application and retention. Particular aspects may be directed to a medical device including a balloon having an outer surface, and a drug coating layer on the outer surface of the balloon. The drug coating layer includes microcrystals in a haystack orientation having random and a substantial absence of uniformity in placement and/or angle on the outer surface of the balloon.
Patent AU-2017280352-A1 (AU)
Title: Methods, systems and apparatus to dynamically facilitate boundaryless, high availability M..N working configuration management with supplemental resource
Inventor: MACHA RAJA RAMANA
IPC: G06F11/30
Filed: 2017-06-23
Abstract: In a Boundaryless Control High Availability ("BCHA") system (e.g., industrial control system) comprising multiple computing resources (or computational engines) running on multiple machines, technology for computing in real time the overall system availability based upon the capabilities/characteristics of the available computing resources, applications to execute and the distribution of the applications across those resources is disclosed. In some embodiments, the disclosed technology can dynamically manage, coordinate recommend certain actions to system operators to maintain availability of the overall system at a desired level. High Availability features may be implemented across a variety of different computing resources distributed across various aspects of a BCHA system and/or computing resources. Two example implementations of BCHA systems described involve an M:N working configuration and M:N + R working configuration.
Patent AU-2017294402-A1 (AU)
Title: Pharmaceutical composition comprising benzydamine
Inventor: FAZIO ANTONELLO
IPC: A61K47/10
Filed: 2017-07-03
Abstract: The present invention relates to a pharmaceutical cream, cream-gel, or gel composition comprising benzydamine having improved tolerability and efficacy for the prevention and treatment of inflammatory and/or infective conditions mainly localized in the genital area, in particular vaginosis, vaginitis and vulvo-vaginitis.
Patent AU-2017296217-A1 (AU)
Title: Adjustable idler support system for conveyor belt
Inventor: RIGGS MARK DANIEL
IPC: B65G21/10
Filed: 2017-07-11
Abstract: An idler support assembly is configured to support a conveyor belt thereon. The idler support assembly includes a frame having a first end and a second end, and a first idler roller coupled to the frame between the first and second ends. The first idler roller is configured to rotate about a first roller axis. The idler support assembly also includes a second idler roller coupled to the frame between the first and second ends. The second idler roller is configured to rotate about a second roller axis. The idler support assembly further includes a first base pivotably coupled to the first end of the frame about a first pivot axis, and an adjustable support selectively coupled to the second end of the frame in a plurality of positions. Each of the plurality of positions defines an angle in which the frame extends relative to the first base.
Patent AU-2017305686-A1 (AU)
Title: Integrated ophthalmic surgical system
Inventor: RAKSI FERENC
IPC: A61F9/008
Filed: 2017-07-31
Abstract: An ophthalmic surgical system includes a chassis comprising a laser source. The system includes a gantry coupled to the chassis. The position of the gantry is adjustable. The system includes a reference interface coupled to the gantry. The reference interface comprises an attachment interface at a distal portion of the reference interface, configured to couple to a patient interface for docking with an eye. The reference interface is configured to move to a first plate position proximal to the chassis and a second plate position distal from the chassis. The system further includes an optical head unit coupled to the reference interface. The optical head unit comprises a laser scanner and a beam splitter. The optical head unit is configured to move to a first head unit position near a proximal end of the reference interface and a second head unit position which is a lockable surgical position near a distal end of the reference interface.
Patent AU-2017332367-A1 (AU)
Title: High mobility group box i mutant
Inventor: THORNE STEPHEN H
IPC: A61K31/00
Filed: 2017-09-21
Abstract: This disclosure relates to modified viruses, e.g., oncolytic vaccinia viruses, which have been modified to contain an exogenous nucleic acid that codes for a variant HMGB1 protein. It provides, at least in part, that vaccinia viruses modified to contain nucleic acid encoding variant HMGB1 and that express a variant HMGB1 or a fragment thereof can achieve a synergistic effect in combination with chemotherapy. Further, this disclosure provides for oncolytic vaccinia viruses and methods of using them in the treatment of various cancers.
Patent AU-2017352557-A1 (AU)
Title: Anti-alcohol-induced dose dumping tablet based on polyvinyl alcohol
Inventor: ZHENG MENGYAO
IPC: A61K9/20
Filed: 2017-11-06
Abstract: The present invention relates to a directly shaped tablet from extrudate based on polyvinyl alcohol (PVA), which can be used for pharmaceutical products, and that due to its improved properties can be better easily shaped into tablets, which show anti-alcohol-induced dose dumping effect. Furthermore, this invention refers to pharmaceutical tablets composition comprising extruded polyvinyl alcohol as carrier matrix and can improve the solubility of API.
Patent AU-2017360168-A1 (AU)
Title: Novel anti-human MUC1 antibody Fab fragment
Inventor: MORINAKA AKIFUMI
IPC: A61P35/00
Filed: 2017-11-17
Abstract: [Problem] To provide an anti-human MUC1 antibody Fab fragment, which is expected to be useful for the diagnosis and/or treatment of cancer, particularly the diagnosis and/or treatment of breast cancer or bladder cancer, and a diagnosis means and/or a therapeutic means using a complex containing the Fab fragment. [Solution] An anti-human MUC1 antibody Fab fragment which contains a heavy chain fragment containing a heavy-chain variable region comprising the amino acid sequence represented by SEQ ID NO: 8 or 10, and a light chain containing a light-chain variable region comprising the amino acid sequence represented by SEQ ID NO: 12; and a complex containing the Fab fragment.
Patent AU-2017367699-A1 (AU)
Title: Fracture targeted bone regeneration through parathyroid hormone receptor stimulation
Inventor: LOW PHILIP S
IPC: A61K31/4535
Filed: 2017-11-30
Abstract: Disclosed herein includes a drug delivery system comprising at least one peptide and a targeting ligand for bone fracture and/or for bone healing. Some embodiments include a peptide delivery system comprising at least an acidic, basic, hydrophilic, hydrohobic or neutral peptide linked to an acidic peptide or nonpeptidic polyanion for use in targeting the aforementioned attached peptide to a bone fracture surface. In some embodiments, a conjugated peptide expresses an anabolic function that acts through PTH receptor 1, and various formats of targeting ligands guide the drug to raw hydroxyapatite. This system offsets some side effects caused by free anabolic drug, such as high blood calcium concentration
Patent AU-2018200095-A1 (AU)
Title: Edge design for reducing photic effects in intraocular lenses
Inventor: ANGELOPOULOS ROBERT D
IPC: A61F2/16
Filed: 2018-01-05
Abstract: An intraocular lens (IOL) formed from a soft, foldable material, has an optic and a peripheral rim. The optic has an anterior optical surface having a first base curvature and a posterior optical surface having a second base curvature. A diameter of the posterior optical surface is greater than a diameter of the anterior optical surface. The first and second base curvatures collectively define an optical power of the optic. The peripheral rim extends between the anterior optical surface and the posterior optical surface and intersects each surface at a respective corner. The peripheral rim defines a cross section having a continuously curving outer edge having a constant radius and that does not include any tangents parallel to an optical axis of the optic.
Patent AU-2018200623-A1 (AU)
Title: Application currency code for dynamic currency conversion transactions with contactless consumer transaction payment device
Inventor: CLEVEN MARC
IPC: G06Q20/00
Filed: 2018-01-25
Abstract: APPLICATION CURRENCY CODE FOR DYNAMIC CURRENCY CONVERSION TRANSACTIONS WITH CONTACTLESS CONSUMER TRANSACTION PAYMENT DEVICE A method comprising receiving (206) data including an account identifier for an account associated with a contactless payment device (CCPTPD) to conduct a transaction in a first currency; parsing the received data to determine (208) whether the received data includes an application currency code for the account associated with the CCPTPD; determining (214) that the transaction is eligible for dynamic currency conversion based on the application currency code when the received data includes the application currency code; obtaining (216) a conversion factor for converting the first currency into a second currency; converting the amount from the first currency to the second currency using the conversion factor to form a total transaction amount in the second currency; and processing the transaction using an authorization request message to request authorization for the transaction, the authorization request message including the total transaction amount in the second currency and a cryptogram generated based on the application currency code.
Patent AU-2018200717-A1 (AU)
Title: Wheel Holder for a Bicycle Carrier
Inventor: ARVIDSSON ANDREAS
IPC: B60R9/10
Filed: 2018-01-31
Abstract: Wheel holder for a bicycle carrier for a vehicle. The holder has a body with two wheel receiving surfaces having a first plane aligned with a rotation plane of the wheel, and a fastening member with released and secured positions to release and retain the wheel. The fastening member extends diagonally across the first plane and rim of wheel when secured. A void is formed between the two wheel receiving surfaces that are integrally formed in one piece of material. The void receives a portion of the wheel thereby providing two distinct support points. WO 2015/185260 PCT/EP2015/058634 Lo -C \\ -. ' C\N ~c -Tk- .11' \\ I\ 7--t
Patent AU-2018202725-A1 (AU)
Title: Ametropia treatment tracking methods and system
Inventor: BRENNAN NOEL A
IPC: G16H20/00
Filed: 2018-04-19
Abstract: A system, method and computer program product for estimating future axial elongation of an individual's eye as a way to predict and track refractive error progression of an individual. The method includes: receiving, via a computer interface, data relating to refractive change in a prior pre-determined time period for the individual from a reference timepoint; receiving data representing an age of the individual and data representing a current axial length value of the eye as measured at the reference timepoint; calculating, by said processor, a future axial elongation of the eye as a function of the age of the individual, the current axial length value of the eye as measured at the reference timepoint, and the refractive change in the prior pre-determined time period; generating, an output indication of said computed axial elongation of the eye, and using said output indication to select a myopia control treatment for said individual. Q.0 >~ rr 0C (D 0 Crt IL -0 -'~ 0 ( -- -- --- 0D.)= S2 .- 1 0 F" 0ac0
Patent AU-2018216105-A1 (AU)
Title: Quality control method, quality control system, management apparatus, analyzer, and quality control abnormality determination method
Inventor: FUJIMOTO KEIJI
IPC: G01N35/00
Filed: 2018-01-11
Abstract: Provided are an accuracy management method, an accuracy management system, a management device, an analysis device, and a method for determining an abnormality in accuracy management, whereby the quality of accuracy management can be increased by adequately utilizing measurement results for both an accuracy management material and a sample. An accuracy management method used by a management device 30 connected via a network 13 to analysis devices 20 installed in each of a plurality of facilities 12, wherein first accuracy management information obtained by measurement of an artificially generated accuracy management material by the analysis device 20 of each facility 12 and second accuracy management information obtained by measurement of a plurality of samples are acquired via the network 13 from the analysis device 20 of each facility 12, and information relating to accuracy management of the analysis device 20 of at least one facility 12 is outputted on the basis of the acquired first accuracy management information and the second accuracy management information.
Patent AU-2018223124-A1 (AU)
Title: Distributed antenna systems for multi-operator networks
Inventor: LEWIS MICHAEL
IPC: H04W88/08
Filed: 2018-02-20
Abstract: There is provided mechanisms for controlling sample rate and frequency shift of a digital signal in a multi-operator network. A method is performed by a network node. The method comprises obtaining a frequency difference and a phase difference between two clock domains. One of the clock domains is associated with a radio access network of a network operator of the multi- operator network and the other of the clock domains is associated with a distributed antenna system in the multi-operator network. The method comprises controlling sample rate conversion of the digital signal between the two clock domains using the phase difference. The digital signal is communicated between the radio access network and the distributed antenna system. The method comprises controlling a frequency shift of the digital signal using the frequency difference.
Patent AU-2018225074-A1 (AU)
Title: Compounds and methods for inhibiting EMT pathways to treat cancer, organ fibrosis and metabolic disorders
Inventor: DAICH ADAM
IPC: A61P3/08
Filed: 2018-02-19
Abstract: A compound, or a pharmaceutically acceptable salt or isomer thereof, of Formula I: wherein R is hydrogen, alkyl, substituted alkyl, alkenyl, or substituted alkenyl; R
Patent AU-2018225295-A1 (AU)
Title: Reticle disc with fiber illuminated aiming dot
Inventor: BELLAH BRIAN J
IPC: F41G1/12
Filed: 2018-02-06
Abstract: Provided is an illuminated dot reticle for use in a rifle scope (10) having an optical path (16) defined through axially spaced-apart objective (12) and ocular lenses (14) and method manufacturing a reticle disc assembly (24). A reticle disc (26) has a first surface facing the objective lens (12) and a second surface facing the ocular lens (14). A first reticle pattern (32), including a central aiming point (40), is applied to one of the reticle disc surfaces (26). An optical fiber (34) has a proximal end (44) portion and a distal end (36), with a light source (52) configured to deliver light to the proximal end (44) portion of the optical fiber (34). The optical fiber (34) is secured to one of the reticle plate surfaces (28) such that the distal end (36) is positioned to transmit light from the light source (52) toward the ocular lens (14) in the optical path (16), providing an illuminated dot at the central aiming point (40).
Patent AU-2018225736-A1 (AU)
Title: Business verification method and apparatus
Inventor: LI NING
IPC: G06Q10/00
Filed: 2018-02-22
Abstract: The present application discloses a business verification method and apparatus. In the method, a first block chain node packages at least one business request gained from a business memory of its own into a pre-processed block, and broadcasts the pre- processed block to second block chain nodes. If finding that a business memory corresponding thereto does not include a part of the business request in the pre-processed block, a second block chain node may acquire the part of the business request from another block chain node, and carries out consensus verification on the pre-processed block by using the part of the business request and a business request stored in the business memory of its own. If the second block chain node finds, after receiving the pre-processed block, that the business memory corresponding thereto does not include a part of the business request in the pre-processed block, the second block chain node does not directly consider the pre-processed block as failed in the consensus verification. Instead, the second block chain node acquires the missing business request from another block chain node to carry out consensus verification on the pre-processed block. Therefore, the business processing accuracy of the whole block chain business is effectively improve.
Patent AU-2018231072-A1 (AU)
Title: Intradialytic use of sodium thiosulfate
Inventor: SHERMAN CRAIG
IPC: C09K11/08
Filed: 2018-03-06
Abstract: Provided herein are methods for maintaining physiological levels of thiosulfate in a subject undergoing hemodialysis. Also provided herein are methods of administering pharmaceutically acceptable sodium thiosulfate to a subject undergoing hemodialysis.
Patent AU-2018256469-A1 (AU)
Title: Authentication using application authentication element
Inventor: WILSON DAVE WILLIAM
IPC: G06Q20/40
Filed: 2018-10-29
Abstract: A method comprises: receiving, by a server computer, an authentication request message at a mobile device. The method also comprises prompting, by the mobile device, a user to select a type of user authentication; receiving, by the mobile device, a selected type of authentication; prompting, by the mobile device, the user to enter a user authentication token; receiving, by the mobile device, the user authentication token and generating, by the mobile device, a secret token based upon the user authentication token and the selected type of user authentication used to authenticate the user and transmitting, by the mobile device to server computer, the secret token, wherein the server computer retrieves a secret reference token, compares the received secret token and the secret reference token, and if the secret reference token and the received secret token do not match, the server computer sends a denial message to the mobile device, and if the secret reference token and the received secret token do match, then the server computer initiates an authorization request message for a transaction.